Loading…
5 companies · GEL, thousands · columns ordered by revenue
Only 3 of 5 peers filed FY2024. Switch to FY2020 (4 of 5).
| Line item | Sikharuli | Gidmedi | Apkhazetidan Idzulebit … | N Kiron + | M.zodelavas Hematologiu… |
|---|---|---|---|---|---|
| Total Revenue | 1,145 | 1,139 | 975 | — | — |
| Total COGS | -84 | -120 | -204 | — | — |
| Gross Profit | 1,061 | 1,019 | 771 | — | — |
| Gross Margin | 92.7% | 89.5% | 79.1% | — | — |
| Total Operating Expenses | -1,119 | -877 | -736 | — | — |
| EBITDA | -58 | 142 | 35 | — | — |
| EBITDA Margin | -5.1% | 12.5% | 3.6% | — | — |
| Total D&A | -70 | -106 | -38 | — | — |
| EBIT / Operating Income | -128 | 36 | -3 | — | — |
| Total Interest Income | 43 | — | — | — | — |
| Total Other Income | 21 | 103 | — | — | — |
| Profit Before Tax | -64 | 138 | -3 | — | — |
| Total Income Tax | 0 | 0 | 0 | — | — |
| Net Profit / (Loss) | -59 | 138 | -3 | — | — |
| Net Margin | -5.1% | 12.2% | -0.3% | — | — |
Not every picked company reports every selected year — FY2024: no filing for N Kiron + and M.zodelavas Hematologiu…. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Gidmedi | Healthcare Services | 12.5% | 57th pct | 268 |
| Apkhazetidan Idzulebit … | Healthcare Services | 3.6% | 30th pct | 268 |
| Sikharuli | Healthcare Services | -5.1% | 18th pct | 268 |
| N Kiron + | Healthcare Services | — | no FY data | 268 |
| M.zodelavas Hematologiu… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.